Outcomes of Emotion Regulation Therapy in Young Autistic Adults
Outcomes and Neural Mechanisms of Emotion Regulation Therapy in Young Adults With Autism: A Pilot Feasibility Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- Recruiting
- Institute of Living, Hartford Hospital
-
Contact:
- Michal Assaf, MD
- Phone Number: 860-545-7792
- Email: michal.assaf@hhchealth.org
-
Principal Investigator:
- Michal Assaf, MD
-
Sub-Investigator:
- Gretchen Diefenbach, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of Autism Spectrum Disorder
- Ages 18-40
- Estimated full-scale IQ ≥ 80
- T score > 60 on either the externalizing or internalizing symptoms scores of either the Adult Behavior Checklist (ABC-L) or the Adult Self Report (ASR)
- Participation in previous study at the Olin Center ("Social Emotional Study"; E-HHC- 2018-0241)
Exclusion Criteria:
- Intellectual disability (estimated full scale IQ<80
- History of a significant head injury (severe concussion, hospitalization)
- History of neurosurgery
- History of epilepsy, stroke, MS, a neurodegenerative disorder, or any other neurological disorder
- A current major medical condition (e.g. cancer, heart failure)
- Current substance use (determined by urine screen done to all participants before each MRI scan)
- In-body metal implants (e.g. surgical clips, certain pacemakers) or history of exposure to metal shards or other MRI contraindications
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: ER intervention
Cognitive-behavioral emotion regulation intervention administered twice weekly for 8 weeks.
|
We will administer a cognitive-behavioral treatment targeting emotion dysregulation, including mindfulness skills and other cognitive and behavioral emotion regulation skills.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adult Self Report (ASR)
Time Frame: Baseline
|
Externalizing and internalizing composite scores
|
Baseline
|
|
Adult Self Report (ASR)
Time Frame: 8 weeks
|
Externalizing and internalizing composite scores
|
8 weeks
|
|
Adult Self Report (ASR)
Time Frame: 2 months follow-up
|
Externalizing and internalizing composite scores
|
2 months follow-up
|
|
Adult Behavior Checklist (ABC-L)
Time Frame: Baseline
|
Externalizing and internalizing composite scores
|
Baseline
|
|
Adult Behavior Checklist (ABC-L)
Time Frame: 8 weeks
|
Externalizing and internalizing composite scores
|
8 weeks
|
|
Adult Behavior Checklist (ABC-L)
Time Frame: 2 months follow-up
|
Externalizing and internalizing composite scores
|
2 months follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- R-HHC-2017-0161
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.